Enhancing the usability of systematic reviews by improving the consideration and description of interventions

BMJ (Online)

Volumn 358, Issue , 2017, Pages

  Hoffmann, Tammy C ^a   Oxman, Andrew D ^b   Ioannidis, John P A ^c   Moher, David ^d   Lasserson, Toby J ^e   Tovey, David I ^e   Stein, Ken ^f   Sutcliffe, Katy ^g   Ravaud, Philippe ^h,i   Altman, Douglas G ^j   Perera, Rafael ^j   Glasziou, Paul ^a  

^a BOND UNIVERSITY   (Australia)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e Cochrane Central Executive ^*  (United Kingdom)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^g UNIVERSITY OF LONDON   (United Kingdom)

^h PARIS DESCARTES UNIVERSITY   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL PROTOCOL; DESCRIPTIVE RESEARCH; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; INFORMATION PROCESSING; METHODOLOGY; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; CLINICAL TRIAL (TOPIC); EVIDENCE BASED MEDICINE; LITERATURE; PEER REVIEW; PROCEDURES; PUBLISHING; REPRODUCIBILITY;

CLINICAL TRIALS AS TOPIC; EDITORIAL POLICIES; EVIDENCE-BASED MEDICINE; PEER REVIEW, RESEARCH; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC;

EID: 85025444989     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j2998     Document Type: Review

References (19)

1. Hoffmann TC, Erueti C, Glasziou PP. Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ 2013;347:f3755. doi:10.1136/bmj.f3755
2. Hoffmann TC, Walker MF, Langhorne P, Eames S, Thomas E, Glasziou P. What's in a name? The challenge of describing interventions in systematic reviews: analysis of a random sample of reviews of non-pharmacological stroke interventions. BMJ Open 2015;5:e009051. doi:10.1136/bmjopen-2015-009051
3. Hoffmann TC, Glasziou PP, Boutron I. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687. doi:10.1136/bmj.g1687
4. Page MJ, Shamseer L, Altman DG. Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study. PLoS Med 2016;13:e1002028. doi:10.1371/journal.pmed.1002028
5. Liberati A, Altman DG, Tetzlaff J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100. doi:10.1371/journal.pmed.1000100
6. Shamseer L, Moher D, Clarke MPRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647. doi:10.1136/bmj.g7647
7. Abell B, Glasziou P, Hoffmann T. Reporting and replicating trials of exercise-based cardiac rehabilitation: do we know what the researchers actually did?Circ Cardiovasc Qual Outcomes 2015;8:187-94. doi:10.1161/CIRCOUTCOMES.114.001381
8. Coxeter P, Hoffmann T, Del Mar C. Shared decision making for acute respiratory infections in primary care. Cochrane Database Syst Rev 2014. doi:10.1002/14651858.CD010907.
9. Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010;340:c117. doi:10.1136/bmj.c117
10. Sun X, Ioannidis JP, Agoritsas T, Alba AC, Guyatt G. How to use a subgroup analysis: users' guide to the medical literature. JAMA 2014;311:405-11. doi:10.1001/jama.2013.285063
11. Cochrane Collaboration. Standards for Cochrane new reviews of interventions and their updates [Internet]. 2016 [cited 2017 Jan 14];Available from: http://methods.cochrane.org/news/mecir-update
12. Cochrane Collaboration. Cochrane Training: Template for Intervention Description and Replication (TIDieR). http://training.cochrane.org/ko/resource/template-intervention-description-and-replication-tidier
13. Chalmers I, Bracken MB, Djulbegovic B. How to increase value and reduce waste when research priorities are set. Lancet 2014;383:156-65. doi:10.1016/S0140-6736(13)62229-1
14. Alonso-Coello P, Schünemann HJ, Moberg JGRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ 2016;353:i2016. doi:10.1136/bmj.i2016
15. Glasziou PP, Chalmers I, Green S, Michie S. Intervention synthesis: a missing link between a systematic review and practical treatment(s). PLoS Med 2014;11:e1001690. doi:10.1371/journal.pmed.1001690
16. Mosseri J, Trinquart L, Nizard R, Ravaud P. Meta-analysis of a complex network of non-pharmacological interventions : the example of femoral neck fracture. PLoS One 2016;11:e0146336. doi:10.1371/journal.pone.0146336
17. Thomas J, O'Mara-Eves A, Brunton G. Using qualitative comparative analysis (QCA) in systematic reviews of complex interventions: a worked example. Syst Rev 2014;3:67. doi:10.1186/2046-4053-3-67
18. Baxter SK, Blank L, Woods HB, Payne N, Rimmer M, Goyder E. Using logic model methods in systematic review synthesis: describing complex pathways in referral management interventions. BMC Med Res Methodol 2014;14:62. doi:10.1186/1471-2288-14-62
19. Wells M, Williams B, Treweek S, Coyle J, Taylor J. Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions. Trials 2012;13:95. doi:10.1186/1745-6215-13-95